Keli L. Hill

Array ( [id] => 6454421 [patent_doc_number] => 20100189713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation' [patent_app_type] => utility [patent_app_number] => 12/525514 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27189 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189713.pdf [firstpage_image] =>[orig_patent_app_number] => 12525514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846689 [patent_doc_number] => 20080183097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Methods and Systems for Measuring a Subject\'s Susceptibility to a Seizure' [patent_app_type] => utility [patent_app_number] => 12/020507 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23400 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20080183097.pdf [firstpage_image] =>[orig_patent_app_number] => 12020507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567799 [patent_doc_number] => 07829083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Antibodies to brain specific membrane protein' [patent_app_type] => utility [patent_app_number] => 12/013346 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11310 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829083.pdf [firstpage_image] =>[orig_patent_app_number] => 12013346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439213 [patent_doc_number] => 20100279316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Antibodies to Phosphorylated IRAK4' [patent_app_type] => utility [patent_app_number] => 12/523681 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 43818 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279316.pdf [firstpage_image] =>[orig_patent_app_number] => 12523681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473701 [patent_doc_number] => 20090246867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Glial mitogenic factors, their preparation and use' [patent_app_type] => utility [patent_app_number] => 12/005635 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 78 [patent_no_of_words] => 28168 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246867.pdf [firstpage_image] =>[orig_patent_app_number] => 12005635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6368010 [patent_doc_number] => 20100074896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'ANTAGONISTS OF PGE2 EP3 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/516847 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7954 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074896.pdf [firstpage_image] =>[orig_patent_app_number] => 12516847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576796 [patent_doc_number] => 20100047247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'NERVE ELONGATION PROMOTER AND ELONGATION INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/515241 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13105 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047247.pdf [firstpage_image] =>[orig_patent_app_number] => 12515241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764615 [patent_doc_number] => 20080175826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Methods and systems for extended in vitro culture of neuronal cells' [patent_app_type] => utility [patent_app_number] => 11/985856 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8804 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175826.pdf [firstpage_image] =>[orig_patent_app_number] => 11985856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845474 [patent_doc_number] => 20080181882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Neurgulin 1 (NRG1) - ErbB4 signaling as a target for the treatment of schizophrenia' [patent_app_type] => utility [patent_app_number] => 11/984285 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12737 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181882.pdf [firstpage_image] =>[orig_patent_app_number] => 11984285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739479 [patent_doc_number] => 20080233132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'MULTIPLE SCLEROSIS THERAPY' [patent_app_type] => utility [patent_app_number] => 11/934641 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25015 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233132.pdf [firstpage_image] =>[orig_patent_app_number] => 11934641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585935 [patent_doc_number] => 20090105137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/930115 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19384 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105137.pdf [firstpage_image] =>[orig_patent_app_number] => 11930115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560707 [patent_doc_number] => 09284366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Anti-acetylated huntingtin antibodies and uses therof' [patent_app_type] => utility [patent_app_number] => 11/981830 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 22 [patent_no_of_words] => 26431 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11981830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764617 [patent_doc_number] => 20080175828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Proliferated cell lines and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/981945 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 32610 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175828.pdf [firstpage_image] =>[orig_patent_app_number] => 11981945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753348 [patent_doc_number] => 20080161424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Compositions and Methods for the Systemic Treatment of Arthritis' [patent_app_type] => utility [patent_app_number] => 11/925555 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6459 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161424.pdf [firstpage_image] =>[orig_patent_app_number] => 11925555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751959 [patent_doc_number] => 20080160032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Compositions and Methods for the Systemic Treatment of Arthritis' [patent_app_type] => utility [patent_app_number] => 11/925568 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6462 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160032.pdf [firstpage_image] =>[orig_patent_app_number] => 11925568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222436 [patent_doc_number] => 20100056444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Treatment of Alzheimer\'s Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors' [patent_app_type] => utility [patent_app_number] => 12/444908 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11930 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056444.pdf [firstpage_image] =>[orig_patent_app_number] => 12444908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415866 [patent_doc_number] => 20090041753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Cytokine signaling' [patent_app_type] => utility [patent_app_number] => 11/904634 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 29908 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041753.pdf [firstpage_image] =>[orig_patent_app_number] => 11904634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353174 [patent_doc_number] => 20100086539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy' [patent_app_type] => utility [patent_app_number] => 12/310893 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3048 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086539.pdf [firstpage_image] =>[orig_patent_app_number] => 12310893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758905 [patent_doc_number] => 20080311131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Human Mob-5 (IL-24) receptors and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/892613 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18387 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311131.pdf [firstpage_image] =>[orig_patent_app_number] => 11892613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508020 [patent_doc_number] => 20090081227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'HUMAN AND MAMMALIAN STEM CELL-DERIVED NEURON SURVIVAL FACTORS' [patent_app_type] => utility [patent_app_number] => 11/840884 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7599 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081227.pdf [firstpage_image] =>[orig_patent_app_number] => 11840884 [rel_patent_id] =>[rel_patent_doc_number] =>)